United States Health and Medical Insurance Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027) – Yahoo Finance


The US healthcare insurance market is the largest in the world, without adhering to WHO’s Universal Health Coverage. Although 8% of the US population does not have a health insurance, the United States continues to top the growth in health premiums in North America.
New York, May 03, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report "United States Health and Medical Insurance Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)" – https://www.reportlinker.com/p06272900/?utm_source=GNW
This growth can be attributed to medical inflation, increasing employment, and some carry-over of the benefits from the former US President Obama’s and Trump’s healthcare policies. According to cdc.gov – Centre for Disease Control and Prevention, the United states spent USD 3.8 trillion in 2019 almost 17.7% of the country’s GDP making the average per person expenditure on health in the United States at USD 11,582 which crossed the USD 12,000 mark in 2020. The US government has laid down numerous health care legislations, to provide health cover to a majority of US population.

According to the NAIC (National Association of Insurance Commissioners), more than 68% of health care coverage was provided by private insurance programs, such as PPOs, HMOs, POS plans, etc. The leading 25 insurers in the United States accounted for about USD 130 billion in 2019, of which more than 60% came from top 25 health insurers. About 6% of Americans purchase health insurance in the non-group type, and 50% have insurance provided by theemployer, 35% have insurances from Medicaid or Medicare and Military whereas over 9% remain uninsured as of 2019.


Key Highlights
Increase in the total health expenditure, which includes both public and private spending on the programs that promote health and prevent disease, with the utilization of medical, paramedical, and nursing knowledge and technology
Growth in the overall employment increases the demand for health insurance through both individual and employer-sponsored health coverage


Key Highlights
Government regulations and related policy orders effecting a lot of unprecedented changes in the way healthcare coverage is being offered to the American citizens.
The expensive healthcare insurance and an even expensive treatment did not see any improvement even after repeated state intervention due to the highly privatized sector.

Key Market Trends

High Deduction Health Plans Gaining Popularity among Public

These are plans with a higher deductible than any traditional insurance plan. The monthly premium is usually lower, but one pays more health care costs themselves before the insurance company starts to pay its share (your deductible). A high deductible plan (HDHP) can be combined with a health savings account (HSA), allowing one to pay for certain medical expenses with money free from federal taxes. The IRS defines a high deductible health plan as any plan with a deductible of at least USD 1,350 for an individual, or USD 2,700 for a family. An HDHP’s total yearly out-of-pocket expenses (including deductibles, copayments, and coinsurance) cannot be more than USD 6,650 for an individual, or USD 13,300 for a family (does not apply to out-of-network services).

The enrollment number for these plans continues to grow YoY, as many employees feel the need to combat the rising healthcare prices. Rising consumerization may continue to drive the tremendous growth of voluntary benefits among employees, and therefore, the HDHPs are gaining popularity, in order to manage costs. The large group market with more than 50 employees remains the most popular setting for HDHP and HAS enrollment, according to AHIP. In 2017, 82% of enrollment occurred in large employer settings, followed by the small-employer market (11%) and the individual market (7%)

The ACA and Health care

0.7 million people were enrolled in coverage through the health insurance marketplaces created under the ACA, including 9.2 million who received premium tax credits and 5.3 million who got cost-sharing reductions. In Florida, Mississippi, Alabama, Nebraska and Oklahoma, at least 95% of marketplace enrollees receive premium tax credits and/or cost-sharing subsidies.

Insurers can no longer deny coverage for pre-existing conditions, charge higher premiums based on health status or gender, revoke coverage when someone gets sick or impose annual or lifetime limits. About 54 million people have a pre-existing condition that could have resulted in them being denied coverage in the pre-ACA individual market. Private insurers now must cover a wide range of preventive services at no out-of-pocket costs to consumers. This includes recommended cancer and chronic condition screenings, immunizations, and other services. Nearly 150 million people are enrolled in employer plans or through individual market insurance that must provide these free preventive services.

Insights on Private Health Insurance (PHI) in the United States

About 60% of the US population utilizes private health insurance services to take care of their health needs. PHI usually covers those that are uncovered, or covered partially, under any public health program. The Trump care had its benefits, it had planned to reduce the federal deficit by USD 150 billion by 2026. The Trump Care increased the health savings account (HSA) contributions from USD 3400 to USD 6550. Trump care also provided subsidies for people with pre-existing conditions and repealed consumer tax on prescription drugs, medical devices and some medical plans as well.

According to US Census Bureau, in 2018, private health insurance coverage stood at 68%, significantly higher than the government coverage (32%). Within the various segments of health insurance coverage, employer-based insurance was the most common, which covered about 56% of the population for few months, or all year, followed by Medicaid (19.3%), Medicare (17.2%), direct-purchase coverage (16.0%), and military coverage (4.8%). Private health insurance spending growth is projected to have increased by 0.5%, to 5.6%, in 2017, partly due to the increase in health insurance marketplace premiums. However, the spending is expected to slow by 0.7%, on an average, for 2019-2020

Competitive Landscape

According to a report from the American Medical Association (or AMA), the private health insurance industry is highly concentrated, with 72% of total metropolitan areas lacking significant health insurer competition.

The Henry J. Kaiser Family Foundation measured the competitiveness of the private health insurance market in 2013, using the Herfindahl-Hirschman Index (HHI) as an indicator. The HHI takes into account how much of a market is controlled by each of the companies competing within it (market share), and is expressed in a value between zero and 10,000. The lower the number, the more competitive the market. Higher concentration from the M&A of various health insurers is expected to raise antitrust concerns among consumers. This is a result of the monopoly power of the health insurer, due to the consolidation, which gives them a leverage to raise and maintain the premiums above the competition levels.

Most of the M&A activities are focused on insurance companies tying up with PBMs, to manage the rising healthcare costs. Few examples include CVS merger with Aetna (USD 69 billion). This merger combines CVS’ pharmacies with Aetna’s insurance business, in hopes of lowering costs. Cigna and Express Scripts closed on a USD 67 billion merger, to lower healthcare costs and deliver better outcomes. Walmart and Humana, which had earlier partnered on a low-cost Medicare Part D prescription drug plan, have an impressive array of medical – PBM – retail capabilities focused on serving the growing medicare advantage market.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support
Read the full report: https://www.reportlinker.com/p06272900/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.


Toyota is known for a lot of different things, mainly automobiles, but the company also makes sewing machines, forklifts, robotics, boats and even houses. Of course, the main line of business Toyota handles is automobiles. While being a true leader in the automobile industry, Toyota has dealt with its own setbacks.
Millennials have given up on stocks. Is it time to follow suit?
First, develop a plan (some might call it a budget), said Robert Gilliland, managing director and senior wealth adviser at Concenture Wealth Management. Take into consideration every single possible expense you anticipate after your husband dies, and account for inflation as well. You can break these expenses down into the short term, such as one to five years, the intermediate term, which would be the six- to 10-year span, and the long term, or beyond 10 years.
The billionaire entrepreneur fears that the economic downturn will become worse if this decision is made.
A bull market will eventually replace this bear market. While it's a fool's errand to try to time the market, it's still a good idea to prepare for the next upswing by owning stocks that are well-positioned to benefit from a shift in market sentiment and a macroeconomic tailwind. Below are three top stocks that look ready to soar in the next bull market, and I'd feel comfortable owning any of them in an extended bear market as well.
Cathie Wood makes big bets on potential huge winners. But Ark Invest's top 10 holdings, including Tesla and Roku, have tumbled in 2022.
Early retirement is a dream for many — that can turn into a nightmare.
Think price levels will be back to normal soon? Think again.
JPMorgan Chase says ongoing inflation and an outlook for sharply lower returns for investors means that retirees should toss the long-standing 4% rule. That's the rule that says retirees can safely draw down their savings by 4% per year without … Continue reading → The post JPMorgan Says You Can Safely Withdraw This Much From Your Retirement Accounts Yearly appeared first on SmartAsset Blog.
Air India is close to placing landmark orders for as many as 500 jetliners worth tens of billions of dollars from both Airbus and Boeing as it carves out an ambitious renaissance under the Tata Group conglomerate, industry sources said on Sunday. The orders include as many as 400 narrow-body jets and 100 or more wide-bodies, including dozens of Airbus A350s and Boeing 787s and 777s, they said, speaking on condition of anonymity as finishing touches are placed on the mammoth deal in coming days. Such a deal could top $100 billion dollars at list prices, including any options, and rank among the biggest by a single airline in volume terms, overshadowing a combined order for 460 Airbus and Boeing jets from American Airlines over a decade ago.
Warren Buffett probably doesn't think much about passive income when he invests. Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) portfolio includes a handful of dividend stocks that deliver monster yields at today's share prices. Berkshire Hathaway initiated a position in Paramount Global (NASDAQ: PARA) earlier this year.
And it's not impacting the country equally either.
Investors looking for some unseemly gains will often pivot to the biotech space, a segment for which the term high-risk/high-reward might possibly have been coined. Bear or bull, it can make no difference to these names, which can soar or crash, depending on specific events such as regulatory approval/rejection or strong/disappointing results from a clinical trial. Even so, the gains posted by Ambrx Biopharma (AMAM) in Friday’s session are unusual and particularly eye-catching. The stock soared
This bank stock was beaten down this year for understandable reasons. But the selling effort went too far.
With some CDs and online savings accounts offering the best yields in a decade, now is the time to be strategic with your savings.
Oil prices rose more than 1% in early Asian trade on Monday as a key Canada-United States crude pipeline stayed shut while Russian President Vladimir Putin threatened to cut production in retaliation against a Western price cap on Russian oil exports. On Sunday, Canada's TC Energy said it has not yet determined the cause of the Keystone oil pipeline leak last week in the United States, while also not giving a timeline as to when the pipeline will resume operations. Meanwhile Russia's Putin said on Friday that his country, the world's biggest exporter of energy, could cut oil production and will refuse to sell oil to any country that imposes a "stupid" price cap on Russian agreed by G7 nations.
As we head into the final stretch of 2022, with less than three weeks until we turn the page to 2023, the markets and the economy are sending a series of mixed signals. Stocks have leveled out somewhat over the past month, with reduced volatility compared to the previous six months. At the same time, investors must consider the economic signals – especially persistently high inflation and uncertainty over the Federal Reserve’s interest rate decision this week. It’s a difficult environment for ma
The market rally faces big tests with the upcoming CPI inflation report and Federal Reserve meeting. Here's what to do.
Investors should always remain aware of their risk tolerance, which becomes increasingly important as your position sizes grow and the stakes become larger. Technology conglomerate Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) dominates the internet; its Google search engine conducts 92% of the world's internet searches, a fantastic stat because it shows that no company on earth has been able to set up a notable competitor in any market. Alphabet generates tons of profitable revenue by selling ads to its internet audience; the company's done $282 billion in revenue over the past year, and $62 billion of that (22%) becomes free cash flow, profits that Alphabet can add to its financial war chest.
Axsome Therapeutics (NASDAQ: AXSM) has absolutely sizzled this year. The biotech stock has more than doubled, with most of the gain coming in just the last couple of months. It should file for FDA approvals of AXS-07 in treating migraine and AXS-14 in treating fibromyalgia next year as well.


Leave a Reply

Your email address will not be published. Required fields are marked *